During Congress’s final week in recess, new legislation and amendments that were proposed run the tech policy gamut.

Wugen, Inc., a clinical-stage biotechnology company developing allogeneic, off-the-shelf cell therapies for the treatment of ...

- ISASecure® SDLA certification of the Johnson Controls Global Secure Product Development Process amplifies its commitment to bring cyber resilient solutions to market - Certification to the ISA/IEC ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, ...

In the last three columns, I have been highlighting the excellent booklet called “Visible Ops Security: Achieving Common Security and IT Operations Objectives in 4 Practical Steps,” by Gene Kim, Paul ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of synthetic DNA using its silicon platform, ...

Scientists have identified distinct functions for regions of a super-enhancer that controls gene expression during retina formation, calling it a 'modular' super-enhancer. Enhancers are regions of DNA ...

In humans, a specialized mRNA translation circuit predetermines the competence for heart formation at an early stage of embryonic development, a research team at the Center for Molecular Medicine ...